Palmoplantar pustulosishttps://en.wikipedia.org/wiki/Pustulosis_palmaris_et_plantaris
Palmoplantar pustulosis ose ma'i pustular dermatosis faifaipea (o lona uiga, o le pustulosis po'o le pustular psoriasis) o lo'o i luga o alofilima ma alofilima na'o, e fa'ailoa mai fa'asolopito i totonu o le epidermal pustules ua tumu i neutrophils. Le fa'aogaina o le systemic retinoids na'o ia ma fa'atasi ma le photochemotherapy e fa'aleleia ai fa'amaoniga o palmoplantar pustulosis.

○ Togafiti
Ole Acitretin ole gutu e aoga mo lea ituaiga psoriasis.
#Acitretin
☆ AI Dermatology — Free Service
I le 2022 Stiftung Warentest i'uga mai Siamani, o le fa'amalieina o tagata fa'atau i ModelDerm sa na'o sina maualalo ifo nai lo fa'atalanoaga telemedicine totogi.
  • I lenei tulaga, pompholyx e mafai foi ona masalomia.
  • I le leai o pustula (pustules), eczema lima e mafai foi ona manatu o se suʻesuʻega eseese.
References Palmoplantar Psoriasis 28846363 
NIH
Palmoplantar pustulosis (Pustulosis palmaris et plantaris) o se ituaiga o pustulosis e a'afai tele i le paʻu o ou alofilima ma alofivae. E faʻaalia e pei o le mafiafia o le paʻu ma pe mago, maʻi, poʻo se tuʻufaʻatasiga o ituaiga uma e lua.
Palmoplantar psoriasis is a variant of psoriasis that characteristically affects the skin of the palms and soles. It features hyperkeratotic, pustular, or mixed morphologies.
 Tumor Necrosis Factor Inhibitors 29494032 
NIH
Tumor necrosis factor (TNF)-alpha inhibitors, including etanercept (E), infliximab (I), adalimumab (A), certolizumab pegol (C), and golimumab (G), are biologic agents which are FDA-approved to treat ankylosing spondylitis (E, I, A, C, and G), Crohn disease (I, A and C), hidradenitis suppurativa (A), juvenile idiopathic arthritis (A), plaque psoriasis (E, I and A), polyarticular juvenile idiopathic arthritis (E), psoriatic arthritis (E, I, A, C, and G), rheumatoid arthritis (E, I, A, C, and G), ulcerative colitis (I, A and G), and uveitis (A).